Deoxyadenosine has been implicated as the toxic metabolite causing profound lymphopenia in immunodeficient children with a genetic deficiency of adenosine deaminase (ADA), and in adults treated with the potent ADA inhibitor deoxycoformycin. However, the biochemical basis for deoxyadenosine toxicity toward lymphocytes remains controversial. The present experiments have examined in detail the sequential metabolic changes induced in nondividing human peripheral blood lymphocytes by incubation with deoxyadenosine plus deoxycoformycin, or with 2-chlorodeoxyadenosine (CdA), an ADA resistant deoxyadenosine congener with anti-leukemic and immunosuppressive properties. The lymphotoxic effect of deoxyadenosine and CdA required their phosphorylation, and was inhibited by deoxycytidine. As early as 4 h after exposure to the deoxynucleosides, strand breaks in lymphocyte DNA began to accumulate, and RNA synthesis decreased. These changes were followed by a significant fall in intracellular NAD levels at 8 h, a drop in ATP pools at 24 h, and cell death by 48 h. Incubation of the lymphocytes with 5 mM nicotinamide, a NAD precursor and an inhibitor of poly(ADP-ribose) synthetase, prevented NAD depletion. The nicotinamide treatment also rendered the lymphocytes highly resistant to deoxyadenosine and CdA toxicity, without altering dATP formation or the accumulation of DNA strand breaks. The poly(ADPribose) synthetase inhibitor 3-aminobenzamide exerted a similar although less potent effect. These results suggest that NAD depletion, probably triggered by poly(ADP-ribose) formation, is the principle cause of death in normal resting human lymphocytes exposed to deoxyadenosine plus deoxycoformycin, or to CdA.
Introduction
A genetic deficiency of adenosine deaminase (ADA,' adenosine aminohydrolase, EC 3.5.4.4) causes severe combined immunodeficiency disease in human beings (1) (2) (3) . The selective This is publication number BCR3544 from the Research Institute of Scripps Clinic. lymphopenia observed in ADA-deficient patients has been attributed to the toxic effects of deoxyadenosine (4) (5) (6) (7) . When compared with other cell types, human T lymphoblasts exposed to deoxyadenosine in the presence of a strong ADA inhibitor, such as deoxycoformycin, preferentially accumulate deoxyadenosine-5'-triphosphate (dATP) (8) (9) (10) . The dATP is an established inhibitor of mammalian ribonucleotide reductase, and hence of DNA synthesis (I 1, 12). However, micromolar concentrations of deoxyadenosine are also toxic to ADAinhibited human peripheral blood lymphocytes that are arrested in prolonged Go phase (13) (14) (15) . The ADA-resistant deoxyadenosine congener 2-chlorodeoxyadenosine (CdA) is similarly cytotoxic to resting human T cells, and has immunosuppressive and anti-leukemic properties (16, 17) .
The metabolic effects of deoxyadenosine in nondividing human lymphocytes have been investigated in several laboratories. Deoxyadenosine has been reported to block RNA synthesis (18) , to decrease ATP levels (15, 19) , and to foster an accumulation of strand breaks in DNA (20) . The actual importance of these events in causing cell death is entirely unknown.
Recent studies indicate that the repair of DNA strand breaks in eukaryotic cells is closely linked to the synthesis of poly(ADP-ribose) (21) (22) (23) . This polymer is produced from NAD in a reaction catalyzed by the chromatin-associated enzyme poly(ADP-ribose) synthetase (24) . Treatment of cells with agents which damage DNA has been shown to stimulate the synthesis of poly(ADP-ribose), resulting in rapid consumption of cellular NAD (25) (26) (27) .
In the present experiments, we have monitored the sequence of metabolic changes that follow exposure of normal human peripheral blood lymphocytes to deoxyadenosine plus deoxycoformycin, or to CdA. An analysis of the data indicates that both deoxynucleosides kill resting lymphocytes mainly by lowering NAD pools. Supplementation of the medium with nontoxic concentrations of nicotinamide prevented NAD depletion and thereby protected the cells from deoxyadenosine and CdA toxicity.
conditions, deoxyadenosine levels in the medium were preserved for at least 72 h.
For toxicity and metabolic studies, 5-ml suspensions of mononuclear cells were maintained in tissue culture flasks at 370C in an atmosphere of 5% CO2 in air. At intervals after the initiation of culture, the nonadherent lymphocytes were removed and processed. Cell viability was determined microscopically after the addition of erythrocin B. Measurement of DNA strand breaks. DNA strand breaks in the various lymphocyte suspensions were measured by the fluorometric method of Birnboim and Jevcak (29) . The assay is based on the observation that the rate of DNA strand unwinding in alkaline solution is inversely related to the length of intact double-stranded DNA segments (30, 31). In previous experiments, the strand unwinding rate correlated well with the number of breaks, or alkali-sensitive sites induced in DNA by gamma irradiation (29, 32) . The fluorescence of ethidium bromide increases when the dye binds to double-stranded DNA (33) . Therefore, a quantitative estimate of DNA strand breaks in treated cells can be made by monitoring the fluorescence of ethidium bromide added to DNA samples in alkaline solutions.
Each unwinding assay contained three sets of data points. Total fluorescence derived from cultures in which DNA unwinding was prevented. Background fluorescence came from cell suspensions that had been sonicated to permit complete DNA unwinding. The test samples provided the third set of data points. The percent residual double-stranded DNA after alkali treatment was calculated by the equation (29): Percent double-stranded DNA = (sample fluorescence -background fluorescence)/(total fluorescence -background fluorescence) X 100.
After incubation with various agents, 107 lymphocytes were resuspended in 2 ml of a 10-mM sodium phosphate buffer (pH 7.2) containing 0.25 M inositol and I mM MgCl2. Aliquots of 0.2 ml were distributed among nine assay tubes for triplicate measurements of total, background, and test condition DNA fluorescence. Cells were lysed by adding 0.2 ml to each tube of a solution containing 9 M urea, 10 mM NaOH, 2.5 mM diaminocyclohexane-tetraacetate, and 0.1% sodium dodecyl sulfate. Lysis was complete after 10 min at 0C. At this time, 0.4 ml of 1 M glucose and 14 mM 2-mercaptoethanol were added to total fluorescence tubes to prevent DNA unwinding. All tubes then received 0.2 ml of 0.2 N NaOH, which raised the pH of the test and background samples to pH 12.8 and that of the total fluorescence tubes to pH 11.2. Background aliquots were then briefly sonicated. Individual samples were incubated at 0C for 30 min and then at 18'C for intervals from 0 to 90 min. DNA unwinding was stopped by adding 0.4 ml of I M glucose and 14 mM 2-mercaptoethanol to test and background tubes. Ethidium bromide, 6.7 ug/ml, in 13.3 mM NaOH was added to each sample. Finally, the relative fluorescence intensity was measured in a filter fluorometer (excitation 520 nm, analyzer 565-600 nm).
As determined by this method, double-stranded DNA from untreated lymphocytes and from irradiated cells decreased linearly during 60 min incubation in alkaline solution (Fig. 1 removal of precipitated material, the supernatants were diluted with water, frozen, and then lyophilized. The nucleotides were dissolved in water just before analysis by high performance liquid chromatography (HPLC). Measurements of intracellular nucleotides. ATP and dATP were measured by HPLC as described previously (36) . NAD pools were measured by an enzymatic cycling assay which was linear in the range from 6.25 to 200 pmol NAD (34, 37) . Each reaction tube contained 0.2 ml of either cell extract or NAD standard, 0.1 ml alcohol dehydrogenase (160 U/ml, Sigma Chemical Co., St. Louis, MO), and I ml of a reaction mixture consisting of 600 mM ethanol, 0.5 mM methyl thiazolyl tetrazolium (MTT), 2.0 mM phenazine ethosulfate, 5.0 mM ethlenediaminetetraacetic acid, 1 mg bovine serum albumin, and 120 mM N-bis(2-hydroxyethyl)glycine, pH 7.8. The cycling assay was initiated at 370C in the dark and was terminated after 20 min by adding 0.5 ml of 12 mM iodoacetate. The optical density of reduced MTT was measured at 570 nm. Reagents. CdA was synthesized enzymatically from 2-chloroadenine as previously described (36) (Fig. 3) . In lymphocyte cultures supplemented with 10 MM deoxyadenosine, or 1 MM CdA, the alkali resistant double-stranded DNA had decreased to <50% of control values by 24 h. Deoxycoformycin alone or 100 MM deoxyadenosine without deoxycoformycin produced results similar to control up to 24 h incubation (results not shown).
CdA, as well as deoxyadenosine plus deoxycoformycin, blocked RNA synthesis in normal resting human lymphocytes (Table I ). The decrease in [5-3H] uridine incorporation was measurable 4 h after the addition of the deoxynucleosides, and continued in parallel with the accumulation of DNA strand breaks (Fig. 3) .
Changes in NAD and ATP levels. DNA damage in mammalian cells stimulates the synthesis of poly(ADP-ribose) from NAD (21, 25, 26) . Lymphocyte NAD levels fell significantly 8 h after exposure to deoxyadenosine plus deoxycoformycin, or to CdA (Fig. 4) . By 24 h, NAD pools were severely depleted. In contrast, lymphocyte ATP pools had not markedly changed after 8 h incubation with deoxyadenosine or CdA (Fig. 5 ). In agreement with earlier results, ATP levels decreased significantly after 24 h exposure to the two deoxynucleosides (15, 19) . Table II summarizes the time course of the effects of deoxyadenosine on ADA inhibited resting human peripheral blood lymphocytes. Notably, the sequence of significant changes was: DNA strand breakage and RNA synthesis inhibition at 4 h; a drop in NAD levels at 8 h; and a fall in ATP concentrations at 24 h. As shown in Fig. 2 , substantial cell death occurred after 48 h incubation with the deoxynucleosides.
Effects of nicotinamide and 3-ABA. Lymphocyte NAD levels reflect a balance between synthesis and consumption. Nicotinamide is both a potential NAD precursor (38) and an inhibitor of poly(ADP-ribose) synthesis (39, 40) . By comparison, 3-ABA is a potent inhibitor of poly(ADP-ribose) synthetase (41), but has not been reported to enhance NAD synthesis. Therefore, we examined the ability of the two agents to modify the toxic and metabolic effects of deoxyadenosine and CdA. 5 mM nicotinamide, and to lesser extent 5 mM 3-ABA, protected resting human peripheral blood lymphocytes from the lethal effects of deoxyadenosine plus deoxycoformycin or CdA (Fig. 6 ). For example, in deoxycoformycin-supplemented medium, 1 MM deoxyadenosine killed >50% of the cells after 3 d incubation. By contrast, in medium containing 1 or 5 mM nicotinamide, the lymphocytes remained viable even in the presence of 100 MM deoxyadenosine. The beneficial effects of nicotinamide were not attributable to inhibition of deoxyadenosine transport or phosphorylation. As shown in Fig. 7 , 5 mM nicotinamide did not alter dATP formation from deoxyadenosine. Moreover, nicotinamide had no effect on the accumulation of DNA strand breaks (Fig. 8) .
The addition of increasing concentrations of nicotinamide to the lymphocyte cultures dose responsively expanded intracellular NAD pools. In the experiment shown in Fig. 9 1 mM nicotinamide elevated the NAD pools threefold. The treatment also retarded the drop in NAD concentrations that followed exposure of the cells to deoxyadenosine or CdA. After 48 h incubation in a medium containing 5 mM nicotinamide and either 10 MM deoxyadenosine plus deoxycoformycin or 1 MM CdA, lymphocyte NAD levels were equivalent to the levels in cells that had not been exposed to the drugs. ATP pools were also higher in the nicotinamide-supplemented cultures (results not shown).
5 mM 3-ABA increased lymphocyte NAD pools only slightly, and was only partially effective in preventing the decline in NAD levels caused by deoxyadenosine. Approximately 1 MM deoxyadenosine blocked by 50% the growth of the human CEM T lymphoblastoid cell line in deoxycoformycin-supplemented medium (9) . Neither nicotinamide (1-5 mM) nor 3-ABA (5 mM) altered the growth inhibitory effects of deoxyadenosine toward the malignant T lymphoblasts.
Effects of deoxycytidine. Deoxycytidine is a competitive inhibitor of deoxyadenosine and CdA phosphorylation in human lymphocytes (4, 10, 36) . In deoxycytidine-supplemented medium, dATP formation from deoxyadenosine was impaired (Fig. 7) and DNA strand breaks did not accumulate during 24 h incubation. As previously reported, deoxycytidine protected resting peripheral blood lymphocytes from the lethal effects of deoxyadenosine and CdA (4, 13, 14) .
Effects of thiopurines. The purine anti-metabolites 6-thioguanine and 6-mercaptopurine blocked RNA synthesis in resting lymphocytes as effectively as deoxyadenosine, but did not trigger the accumulation of DNA strand breaks (Table  III) . Indeed, 3 d exposure to the thiopurines did not significantly impair resting lymphocyte viability.
Discussion
Incubation ofnondividing human peripheral blood lymphocytes with deoxyadenosine plus the strong ADA inhibitor deoxycoformycin, or with the ADA resistant deoxyadenosine analogue CdA, caused a progressive and profound drop in intracellular NAD pools. NAD depletion was measurable as early as 8 h after the addition of the two deoxynucleosides and closely followed the appearance of DNA strand breaks and inhibition of RNA synthesis. The lymphotoxic effects of both deoxyadenosine and CdA were blocked by co-incubation of the cells with nicotinamide, a NAD precursor (38) and inhibitor ofpoly(ADPribose) synthesis (39, 40) . The latter treatment did not alter dATP formation from deoxyadenosine or the accumulation of DNA strand breaks, but preserved intracellular NAD and ATP pools. These results provide a cogent argument for a causal relation between NAD depletion and cell death. The combination ofdeoxyadenosine plus deoxycoformycin partially blocks RNA synthesis in resting human lymphocytes (18) . As shown here, CdA exerts a similar effect. However, the toxicity of the two compounds cannot be attributed to RNA synthesis inhibition, at least in short-term cultures. Presumably, in these long-lived, quiescent cells, incomplete inhibition of RNA synthesis is not an immediately lethal event.
The mechanism by which deoxyadenosine plus deoxycoformycin, or CdA alone, caused the early accumulation of DNA strand breaks in resting Iymphocytes is not entirely clear. However, the present experiments clarify certain aspects of the The accumulation of DNA strand breaks was not itself harmful to resting human lymphocytes. As noted earlier, deoxyadenosine-or CdA-treated lymphocytes incubated in nicotinamide supplemented medium remained viable for 4 d despite a progressive and massive increase in DNA strand breaks. However, the kinetic data, considered along with previous experiments from many laboratories, are consistent with the notion that DNA strand breakage was the event that triggered lethal NAD depletion. It is well established that both DNA-damaging chemicals and ionizing radiation stimulate poly(ADP-ribose) synthesis in normal lymphocytes, and can therefore lower NAD pools (21, 25-27).
Conceivably, a deoxyadenosine metabolite other than dATP may interfere with NAD synthesis or consumption. The 2'-deoxy derivative of NAD, synthesized from dATP, is an established substrate for poly(ADP-ribose) synthetase (43). The NAD analogue also has been reported to inhibit DNA synthesis by isolated nuclei (44) .
Pyridine nucleotides play pivotal roles in cellular metabolism. NAD is a cofactor for many different cellular dehydrogenases (45) , and is a precursor of NADP (46) . Depletion of NADP hampers cellular-reducing power. Moreover, lowering NAD concentrations inhibits glycolysis and ATP generation (47) . This may explain the late decline in ATP levels observed in deoxyadenosine or CdA-treated lymphocyte cultures. Not The experiment was performed as described in Table I surprisingly, a severe fall in NAD pools is incompatible with the survival of resting or proliferating cells. The exquisite sensitivity of thymocytes and mature T lymphocytes to the noxious effects of deoxyadenosine is distinctive among human cell types (4, 13, 15) . In general, the tendency of the cells to accumulate dATP explains their sensitivity to deoxyadenosine. On the other hand, both thymocytes and peripheral blood lymphocytes are destroyed easily by ionizing radiation (48, 49) , and thymocytes are also damaged by corticosteroids (50, 51) . In common with deoxyadenosine and CdA, corticosteroids and ionizing radiation induce DNA strand breaks in lymphocytes, albeit via different mechanisms (29, 52) . Conceivably, NAD depletion is the final common pathway that links the three immunosuppressive modalities.
The factors that regulate the levels of NAD within cells are not well understood. The pyridine nucleotide may be synthesized from tryptophan, nicotinic acid, or nicotinamide (38). The specific activity of the three biosynthetic pathways varies substantially among mammalian cell types (53) . It is possible that the capacity of human lymphocytes for nicotinamide transport, or for NAD synthesis, is limited when compared with other cell types. This prediction needs to be tested experimentally.
Whether or not nicotinamide can modify the lymphotoxic effects of deoxyadenosine in ADA-deficient children remains to be seen. Certainly, nicotinamide treatment would not be expected to revert the deoxyadenosine-mediated block in thymocyte proliferation. However, dietary supplementation with relatively safe concentrations of the vitamin might conceivably improve the function of the few mature T cells that survive in the immunodeficient patients. Considering the usually lethal character of the disease, this hypothesis seems worthy of further testing.
